Every breath carries information.
We turn it into action.

Starting with lung cancer, we’re building a new standard for respiratory diagnostics.

Lung cancer is the leading cause of cancer-related deaths worldwide.

Current tools are failing patients.

Coach explaining stuff to an athlete
Coach explaining stuff to an athlete
Coach explaining stuff to an athlete
0+

million people globally are diagnosed each year

0+

million people globally are diagnosed each year

0+

million people globally are diagnosed each year

0%

percent of patients are diagnosed at Stage IV

0%

percent of patients are diagnosed at Stage IV

0%

percent of patients are diagnosed at Stage IV

0%

of US lung cancer patients don't have molecular profiling

0%

of US lung cancer patients don't have molecular profiling

0%

of US lung cancer patients don't have molecular profiling

0%

of eligible people are not annually screened

0%

of eligible people are not annually screened

0%

of eligible people are not annually screened

Our CEO
Our CEO
Our CEO

OUR TECHNOLOGY


Using our proprietary device and lab tests to improve diagnostic accuracy and speed.

Like the blood, the breath has its own biomarkers that can be used to indicate signs of disease. We are leading in the discovery of these biomarkers and bringing breath diagnostics into regular clinical practice.

Our proprietary device has already been tested with mesothelioma patients and was shown to be 60x more effective than other devices at collecting molecular data from the lungs.

HOW IT WORKS

01

Breath Test

At a clinician's office, an individual breaths into the Respiro device for 3-5 minutes to generate a 2ml sample. This sample contains isolated molecular data from the lungs.

Breath Test

At a clinician's office, an individual breaths into the Respiro device for 3-5 minutes to generate a 2ml sample. This sample contains isolated molecular data from the lungs.

Sample Processed

The sample is then sent to the Respiro Lab, where it is processed using our proprietary methodology.

Sample Processed

The sample is then sent to the Respiro Lab, where it is processed using our proprietary methodology.

02

03

Results Provided

Respiro then sends the results to the clinician, who works with the patient to determine the next steps and make treatment decisions.

Results Provided

Respiro then sends the results to the clinician, who works with the patient to determine the next steps and make treatment decisions.

BENEFITS


Our technology provides better insights without radiation or needles.

✓ Enables molecular profiling from the breath, equivalent to that of tissue biopsies.

✓ Detects lung cancer and respiratory disease early, without needles, scans, or radiation (there is 1 radiation induced death for every 13 lives saved from lung cancer screening!)

✓ Can be delivered in primary care settings, improving access and uptake.

Our CEO
Our CEO

OUR FOUNDING TEAM

Our CEO

Alison Quinn

Commercial leader with extensive experience in healthcare product development, go-to-market strategy, and commercial partnerships.

Our CEO

Dr Theo Issitt

A breath analysis expert with 15+ publications in breath and cell biology and years of experience developing and testing breath collection platforms.

With support from

Support non-invasive solutions for earlier detection, diagnoses, and precision medicine.


Created by Respiro Diagnostics

Contact us at Alison@RespiroDiagnostics.com